Dr. Victoria Niklas earned her MD from Harvard Medical School, her master’s degree in Biochemistry and Molecular Biology from Harvard University, and a master’s certificate in Medical Education and Leadership from the Keck School of Medicine at the University of Southern California (USC). She completed her postgraduate medical training in Pediatrics at Children’s Hospital Los Angeles and her Perinatal and Neonatal Medicine fellowship at the David Geffen School of Medicine at the University of California–Los Angeles (UCLA). She previously held academic appointments
at the University of Virginia, Charlottesville; the Keck School of Medicine at USC, Los Angeles; and the University of Central Florida Medical School, Orlando.
Dr. Niklas’ career has focused on neonatal gastrointestinal immunology and the role of human milk components in reducing hospital acquired infections and necrotizing enterocolitis, a devastating disease of
mostly premature newborns. She is currently a Professor of Pediatrics at the David Geffen School of Medicine at UCLA and continues to practice neonatology at the Olive View UCLA Medical Center in Los Angeles.
Dr. Niklas joined Prolacta Bioscience in 2016 as the Chief Scientific and Medical Officer and was responsible for establishing a nutritional to biopharmaceutical pipeline. She continues at Prolacta as the Vice President of Innovation and
Medical Communication, and she serves as a critical advisor and spokesperson for Prolacta’s Research and Development team in the development of next- generation products derived from human milk. Dr.
Niklas is passionate about uncovering the therapeutic potential of human milk and transforming that knowledge into meaningful solutions in healthcare across the lifespan.